Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRELI domain containing 3B pseudogene 5 (PRELID3BP5) is a processed pseudogene found in the human genome, derived as a nonfunctional genomic copy (retrocopy) of the parental gene PRELID3B. As a pseudogene, PRELID3BP5 is not transcribed into a functional protein; no biological or disease functions unique to this locus have been reported. Some pseudogenes can exert regulatory functions at the RNA level in general (such as acting as competing endogenous RNAs or sources of regulatory small RNAs), but there is no direct evidence that PRELID3BP5 impacts cellular processes or disease. This gene is recognized in genomic databases (HGNC:49067, Ensembl:ENSG00000251656, NCBI Gene:106480242) and is not listed as a coding gene, receptor, enzyme, or other classical therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRELI domain containing 3B pseudogene 5 (PRELID3BP5).